Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
2.240
+0.020 (0.90%)
At close: Feb 21, 2025, 4:00 PM
2.230
-0.010 (-0.45%)
After-hours: Feb 21, 2025, 7:49 PM EST
INO's stock price has decreased by -72.58% in the past year and price targets may not have had time to catch up.
Inovio Pharmaceuticals Analyst Ratings
Total Analysts
6
Consensus Rating
Buy
Price Target
$17.00
Upside
+658.93%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $5 → $3 | Hold | Maintains | $5 → $3 | +33.93% | Jan 13, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $18 | Buy | Reiterates | $18 | +703.57% | Jan 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $12 → $5 | Hold | Maintains | $12 → $5 | +123.21% | Nov 18, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $33 → $15 | Buy | Maintains | $33 → $15 | +569.64% | Nov 18, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $7 → $6 | Hold | Maintains | $7 → $6 | +167.86% | Nov 15, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | +212.50% | Oct 4, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $40 → $33 | Buy | Maintains | $40 → $33 | +1,373.21% | Aug 12, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $11 → $8 | Hold | Maintains | $11 → $8 | +257.14% | Aug 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $15 | Hold | Reiterates | $15 | +569.64% | Jul 15, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Initiates $20 | Buy | Initiates | $20 | +792.86% | May 14, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $40 | Buy | Maintains | $40 | +1,685.71% | Mar 8, 2024 |
| RBC Capital | RBC Capital | Hold Reiterates $11 | Hold | Reiterates | $11 | +391.07% | Mar 7, 2024 |
| Oppenheimer | Oppenheimer | Hold → Buy Upgrades $4 | Hold → Buy | Upgrades | $4 | +78.57% | Jan 25, 2024 |
| JMP Securities | JMP Securities | Buy Initiates $12 | Buy | Initiates | $12 | +435.71% | Jan 4, 2024 |
| RBC Capital | RBC Capital | Hold Reiterates $24 | Hold | Reiterates | $24 | +971.43% | May 11, 2023 |
| RBC Capital | RBC Capital | Hold Maintains $36 → $24 | Hold | Maintains | $36 → $24 | +971.43% | Mar 2, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.